Lipoxin A4 attenuates constitutive and TGF-β1-dependent profibrotic activity in human lung myofibroblasts

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2852-2860

  Roach, Katy M ^a   Feghali Bostwick, Carol A ^b   Amrani, Yassine ^a   Bradding, Peter ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; FORMYLPEPTIDE RECEPTOR LIKE 1; LIPOXIN A; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ACTA2 PROTEIN, HUMAN; ACTIN; FORMYLPEPTIDE RECEPTOR; FPR2 PROTEIN, HUMAN; LIPOXIN; LIPOXIN RECEPTOR; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVITY; CELL DEDIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUNG FIBROBLAST; MOLECULAR STABILITY; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SECRETION (PROCESS);

ACTINS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; ENZYME ACTIVATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; LIPOXINS; LUNG; MYOFIBROBLASTS; PHOSPHORYLATION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84941763744     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500936     Document Type: Article

References (41)

1. Raghu, G., D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster. 2006. Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 174: 810-816.
2. Gribbin, J., R. B. Hubbard, I. Le Jeune, C. J. Smith, J. West, and L. J. Tata. 2006. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61: 980-985.
3. Strieter, R. M. 2005. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 128(Suppl 1): 526S-532S.
4. King, T. E., Jr., A. Pardo, and M. Selman. 2011. Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961.
5. Scotton, C. J., and R. C. Chambers. 2007. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321.
6. Gharaee-Kermani, M., B. Hu, S. H. Phan, and M. R. Gyetko. 2009. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 16: 1400-1417.
7. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125.
8. Sanders, Y. Y., P. Kumbla, and J. S. Hagood. 2007. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 36: 226-235.
9. Grinnell, F. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124: 401-404.
10. Hu, B., Z. Wu, and S. H. Phan. 2003. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29: 397-404.
11. Gu, L., Y. J. Zhu, X. Yang, Z. J. Guo, W. B. Xu, and X. L. Tian. 2007. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation. Acta Pharmacol. Sin. 28: 382-391.
12. Jordana, M., A. D. Befus, M. T. Newhouse, J. Bienenstock, and J. Gauldie. 1988. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43: 552-558.
13. Suganuma, H., A. Sato, R. Tamura, and K. Chida. 1995. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 50: 984-989.
14. Shoda, H., A. Yokoyama, R. Nishino, T. Nakashima, N. Ishikawa, Y. Haruta, N. Hattori, T. Naka, and N. Kohno. 2007. Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis. Biochem. Biophys. Res. Commun. 353: 1004-1010.
15. Roach, K. M., H. Wulff, C. Feghali-Bostwick, Y. Amrani, and P. Bradding. 2014. Increased constitutive aSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent. Respir. Res. 15: 155.
16. Serhan, C. N. 2009. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 7 (Suppl 1): 44-48.
17. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361.
18. Bannenberg, G., and C. N. Serhan. 2010. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 1801: 1260-1273.
19. Serhan, C. N. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510: 92-101.
20. Rodgers, K., B. McMahon, D. Mitchell, D. Sadlier, and C. Godson. 2005. Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am. J. Pathol. 167: 683-694.
21. Mitchell, D., K. Rodgers, J. Hanly, B. McMahon, H. R. Brady, F. Martin, and C. Godson. 2004. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 164: 937-946.
22. Börgeson, E., N. G. Docherty, M. Murphy, K. Rodgers, A. Ryan, T. P. O'Sullivan, P. J. Guiry, R. Goldschmeding, D. F. Higgins, and C. Godson. 2011. Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis. FASEB J. 25: 2967-2979.
23. Wu, S. H., Y. M. Zhang, H. X. Tao, and L. Dong. 2010. Lipoxin A(4) inhibits transition of epithelial to mesenchymal cells in proximal tubules. Am. J. Nephrol. 32: 122-136.
24. Krönke, G., N. Reich, C. Scholtysek, A. Akhmetshina, S. Uderhardt, P. Zerr, K. Palumbo, V. Lang, C. Dees, O. Distler, et al. 2012. The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. Ann. Rheum. Dis. 71: 1081-1087.
25. Wu, S. H., X. H. Wu, C. Lu, L. Dong, and Z. Q. Chen. 2006. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am. J. Respir. Cell Mol. Biol. 34: 65-72.
26. Martins, V., S. S. Valenca, F. A. Farias-Filho, R. Molinaro, R. L. Simo es, T. P. T. Ferreira, P. M. e Silva, C. M. Hogaboam, S. L. Kunkel, I. M. Fierro, et al. 2009. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. J. Immunol. 182: 5374-5381.
27. Roach, K. M., S. M. Duffy, W. Coward, C. Feghali-Bostwick, H. Wulff, and P. Bradding. 2013. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis. PLoS One 8: e85244.
28. Roach, K. M., C. Feghali-Bostwick, H. Wulff, Y. Amrani, and P. Bradding. 2015. Human lung myofibroblast TGFb1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels. Fibrogenesis Tissue Repair 8: 5.
29. Zhou, X., W. Wu, H. Hu, J. Milosevic, K. Konishi, N. Kaminski, and S. E. Wenzel. 2011. Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts. Am. J. Respir. Cell Mol. Biol. 45: 1256-1262.
30. Moiseeva, E. P., K. Roach, M. L. Leyland, and P. Bradding. 2011. The Adhesion Receptor Cadm1 on Mast Cells Mediates Adhesion to Lung Fibroblasts and Smooth Muscle. Thorax 66: A18.
31. Woodman, L., S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling. 2008. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-b 1. J. Immunol. 181: 5001-5007.
32. Huang, M., S. Sharma, L. X. Zhu, M. P. Keane, J. Luo, L. Zhang, M. D. Burdick, Y. Q. Lin, M. Dohadwala, B. Gardner, et al. 2002. IL-7 inhibits fibroblast TGFbeta production and signaling in pulmonary fibrosis. J. Clin. Invest. 109: 931-937.
33. Distler, J. H. W., A. Jüngel, L. C. Huber, U. Schulze-Horsel, J. Zwerina, R. E. Gay, B. A. Michel, T. Hauser, G. Schett, S. Gay, and O. Distler. 2007. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 56: 311-322.
34. Chiang, N., C. N. Serhan, S. E. Dahlén, J. M. Drazen, D. W. P. Hay, G. E. Rovati, T. Shimizu, T. Yokomizo, and C. Brink. 2006. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58: 463-487.
35. Pechkovsky, D. V., T. L. Hackett, S. S. An, F. Shaheen, L. A. Murray, and D. A. Knight. 2010. Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression. Am. J. Respir. Cell Mol. Biol. 43: 641-651.
36. Kotaru, C., K. J. Schoonover, J. B. Trudeau, M. L. Huynh, X. Zhou, H. Hu, and S. E. Wenzel. 2006. Regional fibroblast heterogeneity in the lung: implications for remodeling. Am. J. Respir. Crit. Care Med. 173: 1208-1215.
37. Tomasek, J. J., G. Gabbiani, B. Hinz, C. Chaponnier, and R. A. Brown. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3: 349-363.
38. Hasegawa, T., A. Nakao, K. Sumiyoshi, H. Tsuchihashi, and H. Ogawa. 2005. SB-431542 inhibits TGF-b-induced contraction of collagen gel by normal and keloid fibroblasts. J. Dermatol. Sci. 39: 33-38.
39. Raghu, G., S. Masta, D. Meyers, and A. S. Narayanan. 1989. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-b. Am. Rev. Respir. Dis. 140: 95-100.
40. Selman, M., A. Pardo, L. Barrera, A. Estrada, S. R. Watson, K. Wilson, N. Aziz, N. Kaminski, and A. Zlotnik. 2006. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 173: 188-198.
41. Sodin-Semrl, S., B. Taddeo, D. Tseng, J. Varga, and S. Fiore. 2000. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164: 2660-2666.